🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
NVC
$NVCR
🔒 US EquitiesNovocure Ltd
AVG HISTORICAL GAP
+1.30%
MAX GAP RECORD
+15.61%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $NVCR
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$NVCR
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Oct 29, 2026 Earnings Release 2026-10-29 (BEFORE OPEN (08:00)) |
-11.04%
|
| Jul 23, 2026 Earnings Release 2026-07-23 (BEFORE OPEN) |
+15.61%
|
| Apr 30, 2026 Earnings Release 2026-04-30 (BEFORE OPEN) |
+11.99%
|
| Feb 26, 2026 Earnings Release 2026-02-26 (BEFORE OPEN) |
-11.59%
|
| Oct 30, 2025 Earnings Release 2025-10-30 (BEFORE OPEN) |
+0.00%
|
| Jul 24, 2025 Earnings Release 2025-07-24 (BEFORE OPEN) |
-0.06%
|
| Apr 24, 2025 Earnings Release 2025-04-24 (BEFORE OPEN) |
+6.58%
|
| Feb 27, 2025 Earnings Release 2025-02-27 (BEFORE OPEN) |
-8.38%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
6.5%
Bullish Gaps (6)
Bearish Gaps (4)
Neutral / Flat (3)
📖 Intelligence Summary
NovoCure Ltd. is an oncology company which engages in the development, manufacture, and commercialization of Optune for the treatment of a variety of solid tumors. Its platform is called the Tumor Treating Field which uses electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. The company…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗